Skip to main content
Clinical Trials/NCT05323669
NCT05323669
Not yet recruiting
Not Applicable

Study of Molecular-genetic Profile of Thyroid Nodules

Belarusian State Medical University0 sites400 target enrollmentApril 11, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thyroid Cancer
Sponsor
Belarusian State Medical University
Enrollment
400
Primary Endpoint
Molecular profile of thyroid nodules
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

Profiling and comparative analysis of genomic alterations and miRNA expression in benign and malignant thyroid tumors using histological and cytological specimens will be performed. Obtained information is necessary to create a molecular test to refine the cancer risk of cytologically indeterminate thyroid nodules.

Detailed Description

This is an non-randomised retrospective study consisting of 2 parts. Part A. Histological specimens (formalin fixed paraffin embedded) of patients who were operated on for benign and malignant thyroid disorders will undergo molecular testing to create a molecular profile of thyroid nodules characteristic of Belarusian population. Part B. Fixed cytological smears of indeterminate thyroid nodules (categories III, IV and V according to Bethesda scoring system) of operated patients will undergo molecular testing to evaluate the possibility and reliability of molecular testing of fixed cytological smears using available assays.

Registry
clinicaltrials.gov
Start Date
April 11, 2022
End Date
December 31, 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Belarusian State Medical University
Responsible Party
Principal Investigator
Principal Investigator

Siarhei Yakubouski

MD PhD Assistant Professor

Belarusian State Medical University

Eligibility Criteria

Inclusion Criteria

  • Patients operated on for malignant and benign thyroid tumors. Age is greater than or equal to 18 years old.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Molecular profile of thyroid nodules

Time Frame: 2 years

To develop a molecular profile of thyroid nodules that will allow to distinguish benign from malignant tumor

Similar Trials